Get started
Author

Krithikaa Rajkumar Bhanu

Observed name: Krithikaa Bhanu
ORCID: 0000-0003-1871-0054
Observed ORCID: 0000-0003-1871-0054
OpenAlex ID: A5012276971
ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer
2022 · Rodney Cheng-En Hsieh, Sunil Krishnan, et al. · Science Immunology · 182
Biomechanical Regulation of Hematopoietic Stem Cells in the Developing Embryo
2021 · Paulina D. Horton, Sandeep P. Dumbali, et al. · Current Tissue Microenvironment Reports · 12
PDF
592 ATR-mediated CD47 and PD-L1 upregulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer
2021 · Rodney Cheng-En Hsieh, Sunil Krishnan, et al. · Regular and Young Investigator Award Abstracts · 9
PDF
1154 High-potency synthetic STING agonists rewire myeloid subsets in the tumour microenvironment to dismantle immunosuppressive stroma in refractory pancreatic ductal adenocarcinoma
2022 · Akash Boda, Casey Ager, et al. · Regular and Young Investigator Award Abstracts · 2
PDF
Abstract 4213: Targeting the cMet inhibitors combined with anti-PD-1 therapy: Preclinical approach to turn the resistance into opportunities for overcoming tumor evasion
2022 · Ricardo Alexandre de Azevedo, Hsieh Cheng-En, et al. · Cancer Research · 2
Tmic-20. Unlocking the Potential of Hypoxia Reduction in Reshaping the Glioblastoma Tumor Microenvironment for Enhanced Therapeutic Synergy
2024 · Ivana William, Kristin Huntoon, et al. · Neuro-Oncology · 1
PDF
622 Disrupted oxygen supply and tumor hyper- oxygen consumption contribute independently to prostate cancer immune privilege
2021 · Priyamvada Jayaprakash, Meghan Rice, et al. · Regular and Young Investigator Award Abstracts · 1
PDF
760 Tumor oxidative metabolism exhibits atypical dependence on two mitochondrial complex I subunits that are dispensable for T cell function
2025 · Krithikaa Rajkumar Bhanu, Priyamvada Jayaprakash, et al. · Regular and Young Investigator Award Abstracts
PDF
1091 A STING agonist payloaded, tumor-specific antibody sensitizes murine pancreatic cancer to immune checkpoint blockade
2024 · Akash Boda, Shweta M Hegde, et al. · Regular and Young Investigator Award Abstracts
705 Hypoxia-activated prodrugs with distinct mechanisms of action sensitize murine prostate tumors to immune checkpoint blockade
2024 · Priyamvada Jayaprakash, Krithikaa Rajkumar Bhanu, et al. · Regular and Young Investigator Award Abstracts
808 Attacking carbonic anhydrase IX as a gateway to remodeling tumor hypoxia
2024 · Krithikaa Rajkumar Bhanu, Shweta M Hegde, et al. · Regular and Young Investigator Award Abstracts
856 Unlocking the potential of hypoxia reduction in reshaping the glioblastoma tumor microenvironment for enhanced therapeutic synergy
2024 · Ivana William, Spencer Lea, et al. · Regular and Young Investigator Award Abstracts
Abstract 5745: Proposing the best MET inhibitor to improve anti-PD-1 efficacy in HCC
2023 · Ricardo A. de Azevedo, Broderick Turner, et al. · Cancer Research
831 Targeting tumor oxidative metabolism to overcome hypoxia-induced immunotherapy resistance in prostate cancer
2022 · Priyamvada Jayaprakash, Michael Curran, et al. · Regular and Young Investigator Award Abstracts
PDF
Abstract 4183: Differential modulation of tumor versus T cell oxidative phosphorylation potentiates anti-tumor immunity
2022 · Krithikaa Rajkumar Bhanu, Priyamvada Jayaprakash, et al. · Cancer Research
Works count: 15
Citation count: 209
H-index: 3
I10-index: 2
Year
Topic
Type